Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAN-WAR-D
2018-000484-86Phase 4Active
- Sponsor
- Rigshospitalet
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in Atrial fibrillation (AFib) (2 arms), sponsored by Rigshospitalet. Primary endpoint: Primary efficacy outcome. Started Oct 2018; status: active.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2018-000484-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000484-86.